Publicaciones (22) Publicaciones en las que ha participado algún/a investigador/a

2006

  1. Acute and long-term administration of citalopram desensitizes α2-adrenoceptors in the rat vas deferens

    Journal of Pharmacy and Pharmacology, Vol. 58, Núm. 3, pp. 367-373

  2. Brain G protein-dependent signaling pathways in Down syndrome and Alzheimer's disease

    Amino Acids, Vol. 31, Núm. 4, pp. 449-456

  3. Cannabinoid system in the budgerigar brain

    Brain Research, Vol. 1087, Núm. 1, pp. 105-113

  4. Characterization of CB1 cannabinoid receptor immunoreactivity in postmortem human brain homogenates

    Neuroscience, Vol. 140, Núm. 2, pp. 635-643

  5. Cyclic AMP-dependent and Epac-mediated activation of R-Ras by G protein-coupled receptors leads to phospholipase D stimulation

    Journal of Biological Chemistry, Vol. 281, Núm. 31, pp. 21837-21847

  6. Depolarization-induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2-arachidonoylglycerol

    Journal of Physiology, Vol. 577, Núm. 1, pp. 263-280

  7. Development of new drugs that act through membrane receptors and involve an action of inverse agonism.

    Recent patents on CNS drug discovery, Vol. 1, Núm. 2, pp. 207-217

  8. Electrophysiological characterization of substantia nigra dopaminergic neurons in partially lesioned rats: Effects of subthalamotomy and levodopa treatment

    Brain Research, Vol. 1084, Núm. 1, pp. 175-184

  9. Estimación del exceso de riesgo de mortalidad por cáncer de pulmón asociado a la exposición al humo ambiental de tabaco en trabajadores de la hostelería

    Medicina Clinica, Vol. 126, Núm. 1, pp. 13-14

  10. Greater allergenicity of topical ketoprofen in contact dermatitis confirmed by use

    Contact Dermatitis, Vol. 54, Núm. 5, pp. 239-243

  11. Heterotrimeric G proteins: Insights into the neurobiology of mood disorders

    Current Neuropharmacology, Vol. 4, Núm. 2, pp. 127-138

  12. In vivo effect of tramadol on locus coeruleus neurons is mediated by α2-adrenoceptors and modulated by serotonin

    Neuropharmacology, Vol. 51, Núm. 1, pp. 146-153

  13. Levels of G-protein αq/11 subunits and of phospholipase C-β(1-4), -γ, and -δ1 isoforms in postmortem human brain caudate and cortical membranes: Potential functional implications

    Neurochemistry International, Vol. 49, Núm. 1, pp. 72-79

  14. Los receptores para imidazolinas I 2 como posible marcador de malignidad en tumores gliales humanos

    Revista de Neurologia, Vol. 43, Núm. 8, pp. 476-480

  15. Pharmacological characterization and autoradiographic distribution of α2-adrenoceptor antagonist [3H]RX 821002 binding sites in the chicken brain

    Neuroscience, Vol. 141, Núm. 1, pp. 357-369

  16. Screening for MECP2 mutations in Spanish patients with an unexplained mental retardation

    Clinical Genetics, Vol. 70, Núm. 2, pp. 140-144

  17. Separation of μ-opioid receptor desensitization and internalization: Endogenous receptors in primary neuronal cultures

    Journal of Neuroscience, Vol. 26, Núm. 15, pp. 4118-4125

  18. Synthesis and pharmacological studies of new hybrid derivatives of fentanyl active at the μ-opioid receptor and I2-imidazoline binding sites

    Bioorganic and Medicinal Chemistry, Vol. 14, Núm. 19, pp. 6570-6580

  19. Systemic effect of cannabinoids on the spontaneous firing rate of locus coeruleus neurons in rats

    European Journal of Pharmacology, Vol. 534, Núm. 1-3, pp. 83-88

  20. The N251K functional polymorphism in the α2A-adrenoceptor gene is not associated with depression: A study in suicide completers

    Psychopharmacology, Vol. 184, Núm. 1, pp. 82-86